Vinay Badhwar, M.D., executive chair of the WVU Heart and Vascular Institute and chair of the Department of Cardiovascular and Thoracic Surgery, and Mohamad Alkhouli, M.D., interventional cardiologist and director of the WVU Heart and Vascular Institute Structural Heart Disease Program, will help lead the trial of the new Tendyne transcatheter mitral valve replacement device.
Research
Today (Aug. 1) WVCTSI will host its first REDCap Help Clinic to provide WVCTSI members with interactive assistance. During these sessions, participants can receive guidance and ask questions on a variety of REDCap topics including project initiation, features, functionality, and more.
What do one in five breast cancers have in common? Large amounts of a protein called HER2 (or human epidermal growth factor receptor 2). “Every healthy cell produces a normal amount of HER2, but HER2 is produced 10 to 20 times more in a cancer cell,” said Yehenew Agazie, an associate professor of biochemistry at the West Virginia University School of Medicine.
WV-INBRE program will provide funding for HSTA scholars attending WVU and Marshall University to participate in biomedical science research. A maximum of six internships (three for WVU/three for MU) will be available.
West Virginia University (WVU) has been selected as the first site for an innovative clinical trial to treat Alzheimer’s disease. Ali Rezai, M.D., director of the WVU Rockefeller Neuroscience Institute, will lead the initiative in collaboration with INSIGHTEC, an Israel-based medical technology company who received approval by the U.S. Food and Drug Administration (FDA) to begin the clinical trial using focused ultrasound to treat Alzheimer’s.
Dr. Thomas Bias and Emily Sarkees traveled to Keyser to work with Potomac Valley Hospital leadership in facilitating a community meeting as part of their Community Health Needs Assessment process.